Benito Yard

Heidelberg University

Papers

1

Total Citations

8

H-Index

1

About

Benito Yard is a leading researcher in diabetic nephropathy and the molecular mechanisms of kidney disease, with a particular focus on the role of carnosinase enzymes. His major contributions center on elucidating how carnosinase 1 (CN1) polymorphisms and activity levels influence the progression of diabetic kidney disease (DKD). In his highly cited 2022 study, Yard established a critical association between serum carnosinase concentration and activity and renal function impairment in a type-2 diabetes cohort, demonstrating that CN1 levels could serve as diagnostic or prognostic markers for DKD. This work, garnering 8 citations, has opened new avenues for early detection and therapeutic targeting in diabetic patients. Yard’s research bridges genetic insights with clinical application, offering a deeper understanding of how enzymatic pathways drive kidney damage. His findings have significant implications for personalized medicine in nephrology, potentially guiding interventions to slow disease progression. Yard’s dedication to translating molecular discoveries into practical biomarkers marks him as a pivotal figure in the fight against diabetic complications, inspiring further investigation into carnosinase-based diagnostics and therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Heidelberg University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago